The process of incorporating insulin pumps into the everyday lives of people with Type 1 diabetes: A critical interpretive synthesis

Health Expectations

Volumn 21, Issue 4, 2018, Pages 714-729

  Reidy, Claire ^a   Bracher, Mike ^a,b   Foster, Claire ^a   Vassilev, Ivaylo ^a   Rogers, Anne ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b BOURNEMOUTH UNIVERSITY   (United Kingdom)

Author keywords

critical interpretive synthesis; insulin pumps; new technology; psychosocial; social support networks; Type 1 diabetes

Indexed keywords

INSULIN;

HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HUMAN; INFUSION PUMP; INSULIN DEPENDENT DIABETES MELLITUS; MASS COMMUNICATION; QUALITY OF LIFE; SELF CARE;

DELIVERY OF HEALTH CARE; DIABETES MELLITUS, TYPE 1; DIFFUSION OF INNOVATION; HEALTH PERSONNEL; HUMANS; INFUSION PUMPS; INSULIN; QUALITY OF LIFE; SELF-MANAGEMENT;

EID: 85041715191     PISSN: 13696513     EISSN: 13697625     Source Type: Journal    
DOI: 10.1111/hex.12666     Document Type: Review

References (102)

1. Diabetes UK (2016). Facts and Stats. [online] London: Diabetes UK, pp.1-17. Available at: https://diabetes-resources-production.s3-eu-west-1.amazonaws.com/diabetes-storage/migration/pdf/DiabetesUK_Facts_Stats_Oct16.pdf [Accessed 13 Dec. 2018].
2. Hoogma RP, Hammond PJ, Gomis R, et al. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabet Med. 2006;23:141-147.
3. Hoogma RPL, Hoekstra JB, Michels BP, Levi M. Comparison between multiple daily insulin injection therapy (MDI) and continuous subcutaneous insulin infusion therapy (CSII), results of the five nations study. Diabetes Res Clin Pract. 2006;74:S144-S147.
4. Kerr D, Nicholls H, James J. Continuous subcutaneous insulin infusion (CSII insulin pump therapy) for type 1 diabetes: a Bournemouth perspective. Pract Diabetes Int. 2008;25:114-117.
5. Hilliard ME, Goeke-Morey M, Cogen FR, Henderson C, Streisand R. Predictors of diabetes-related quality of life after transitioning to the insulin pump. J Pediatr Psychol. 2009;34:137-146.
6. Muller-Godeffroy E, Treichel S, Wagner VM. Investigation of quality of life and family burden issues during insulin pump therapy in children with Type 1 diabetes mellitus–a large-scale multicentre pilot study. Diabet Med. 2009;26:493-501.
7. Lynch C, Qazi S, Stalker AJ, et al. Insulin pump (CSII) therapy improves the Quality of Life (QoL) in patients with diabetes: the derby experience. Diabet Med. 2010;27(Suppl 1):153.
8. Misso Marie L, Egberts Kristine J, Page M, O'Connor D, Shaw J. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2010;(1):CD005103.
9. Yi-Frazier JP, Smith RE, Vitaliano PP, et al. A person-focused analysis of resilience resources and coping in diabetes patients. Stress Health. 2010;26:51-60.
10. Clark LF, Bilbie JC, Abraham P. What do patients prefer: insulin pumps or multiple daily injections and structured education? A retrospective audit and patient questionnaire. Pract Diabetes Int. 2011;28:73-75.
11. Alsaleh FM, Smith FJ, Taylor KM. Experiences of children/young people and their parents, using insulin pump therapy for the management of type 1 diabetes: qualitative review. J Clin Pharm Ther. 2012;37:140-147.
12. Cropper J, Kanchi L, Ford-Adams M, Hulse T, Buchanan C, Barker E. Quality of life and HbA1c outcomes in children and young people commencing insulin pump therapy. Endocrine Abstracts. 2012;30:18-19.
13. Salehi S, Addington H, Turner K, Vithian K. An audit investigating how clinical outcomes on pump services can be achieved through intensive follow-up via face-to-face and distance consultation. Diabet Med. 2014;31(Suppl 1):74.
14. Bonfanti R, Lepore G, Bozzetto L, et al. Survey on the use of insulin pumps in Italy: comparison between pediatric and adult age groups (IMITA study). Acta Diabetol. 2016;53:403-412.
15. Ghazanfar H, Rizvi SW, Khurram A, Orooj F, Qaiser I. Impact of insulin pump on quality of life of diabetic patients. Indian J Endocrinol Metab. 2016;20:506-511.
16. Barnard KD, Skinner TC. Qualitative study into quality of life issues surrounding insulin pump use in type 1 diabetes. Pract Diabetes Int. 2007;24:143-148.
17. Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes. Diabetes Care. 1996;19:324-327.
18. McMahon SK, Airey FL, Marangou DA, et al. Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life. Diabet Med. 2005;22:92-96.
19. Silverstein J, Klingensmith G, Copeland K, et al. Care of children and adolescents with type 1 diabetes. A statement of the American Diabetes Association. Diabetes Care. 2005;28:186-212.
20. Kesavadev J, Das AK, Unnikrishnan R, et al. Use of insulin pumps in India: suggested guidelines based on experience and cultural differences. Diabetes Technol Ther. 2010;12:823-831.
21. Lawton J, Kirkham J, Rankin D, et al. Who gains clinical benefit from using insulin pump therapy? A qualitative study of the perceptions and views of health professionals involved in the Relative Effectiveness of Pumps over MDI and Structured Education (REPOSE) trial. Diabet Med. 2016;33:243-251.
22. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care. 2003;26:1079-1087.
23. Bruttomesso D, Crazzolara D, Maran A, et al. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabet Med. 2008;25:326-332.
24. Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med. 2008;25:765-774.
25. Riveline JP, Jollois FX, Messaoudi N, et al. Insulin-pump use in everyday practice: data from an exhaustive regional registry in France. Diabetes Metab. 2008;34:132-139.
26. Chellamuthu P, Lawrence IG, Kitchener D, et al. Continuous subcutaneous insulin infusion: experience from a large specialist service: are we following NICE guidance and what is the added benefit of the DAFNE programme? Pract Diabetes Int. 2009;26:60-64.
27. Pankowska E, Blazik M, Dziechciarz P, Szypowska A, Szajewska H. Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabetes. 2009;10:52-58.
28. de Bock M, Gunn AJ, Holt JA, et al. Impact of insulin pumps on glycaemic control in a pump-naive paediatric regional population. J Paediatr Child Health. 2012;48:247-252.
29. Pickup JC. Management of diabetes mellitus: is the pump mightier than the pen? Nat Rev Endocrinol. 2012;8:425-433.
30. Shanmugasundaram M, Karamat M, Hand J, Field A, Charlton M, Dyer P. The impact of continuous subcutaneous insulin infusion in patients with Type 1 diabetes. Diabet Med. 2012;29(Suppl 1):175.
31. Johnson SR, Cooper MN, Jones TW, Davis EA. Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study. Diabetologia. 2013;56:2392-2400.
32. Quiros C, Gimenez M, Rios P, et al. Long-term outcome of insulin pump therapy: reduction of hypoglycaemia and impact on glycaemic control. Diabet Med. 2016;33:1422-1426.
33. Alcolado J, Bailey K, Cuthbert S, Warren S. CSII therapy: the Cardiff experience. Diabetes Prim Care. 2008;10:103-106.
34. Jakisch BI, Wagner VM, Heidtmann B, et al. Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years. Diabet Med. 2008;25:80-85.
35. Dissanayake S, Sittampalam V, Kong N. Audit on continuous subcutaneous insulin infusion (insulin pump) therapy in a district general hospital. Diabet Med. 2009;24(Suppl 1):81.
36. Gane J, White B, Christie D, Viner R. Systematic review and meta-analysis of insulin pump therapy in children and adolescents with type 1 diabetes. Arch Dis Child. 2010;95(Suppl 1):A94.
37. Cook CB, Beer KA, Seifert KM, Boyle ME, Mackey PA, Castro JC. Transitioning insulin pump therapy from the outpatient to the inpatient setting: a review of 6 years’ experience with 253 cases. J Diabetes Sci Technol. 2012;6:995-1002.
38. National Institute for Health and Clinical Excellence. NICE Technology Appraisal Guidance 151. Continuous Subcutaneous Insulin Infusion for the Treatment of Diabetes Mellitus (Review of Technology Appraisal Guidance 57). London: National Institute for Health and Clinical Excellence; 2008.
39. Nicolucci A, Maione A, Franciosi M, et al. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections. Diabet Med. 2008;25:213-220.
40. Carreira M, Anarte MT, Colomo N, et al. Effect of a telemedicine system on adherence to treatment in patients with type 1 diabetes and insulin-pump therapy. Diabetes Technol Ther. 2013;15:A102.
41. Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ. 2002;324:705.
42. Aathira R, Jain V. Advances in management of type 1 diabetes mellitus. World J Diabetes. 2014;5:689-696.
43. Johnson SB, Kelly M, Henretta JC, Cunningham WR, Tomer A, Silverstein JH. A longitudinal analysis of adherence and health status in childhood diabetes. J Pediatr Psychol. 1992;17:537-553.
44. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32:1335-1343.
45. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
46. Wilmot EG, Choudhary P, Grant P, Hammond P. Insulin pump therapy: a practical guide to optimising glycaemic control. Pract Diabetes. 2014;31:121-125a.
47. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care. 2002;25:593-598.
48. American Diabetes Association. Standards of medical care in diabetes 2017. Diabetes Care. 2017;40(Suppl 1):S4-S5.
49. Mecklenburg RS, Benson JW Jr, Becker NM, et al. Clinical use of the insulin infusion pump in 100 patients with type I diabetes. N Engl J Med. 1982;307:513-518.
50. McAdams BH, Rizvi AA. An overview of insulin pumps and glucose sensors for the generalist. J Clin Med. 2016;5:5.
51. Low KG, Massa L, Lehman D, Olshan JS. Insulin pump use in young adolescents with type 1 diabetes: a descriptive study. Pediatr Diabetes. 2005;6:22-31.
52. Alsaleh FM, Smith FJ, Thompson R, Al-Saleh MA, Taylor KMG. Insulin pump therapy: impact on the lives of children/young people with diabetes mellitus and their parents. Int J Clin Pharm. 2014;36:1023-1030.
53. Steineck I, Cederholm J, Eliasson B, et al. Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study. BMJ. 2015;350:h3234.
54. Hussain T, Akle M, Nagelkerke N, Deeb A. Comparative study on treatment satisfaction and health perception in children and adolescents with type 1 diabetes mellitus on multiple daily injection of insulin, insulin pump and sensor-augmented pump therapy. SAGE Open Med. 2017;5:2050312117694938.
55. Pickup JC. Point: are insulin pumps underutilized in type 1 diabetes? Yes. Diabetes Care. 2006;29:1449-1452.
56. White HD, Goenka N, Furlong NJ, et al. The U.K. service level audit of insulin pump therapy in adults. Diabetic medicine. 2014;31:412-418.
57. Barnard K. D., Lloyd C. E., and Skinner T. C. Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetes. Diabetic Medicine. 2007;24:607-617. doi:10.1111/j.1464-5491.2007.02120.x
58. Noblit G, Hare R. Meta-ethnography: Synthesising Qualitative Studies. Newbury Park, CA: Sage; 1988.
59. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
60. Thomas J, Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol. 2008;8:45.
61. Garmo A, Hörnsten Å, Leksell J. ‘The pump was a saviour for me’. Patients’ experiences of insulin pump therapy. Diabet Med. 2013;30:717-723.
62. Tullman AJ. A Phenomenological Study of the Psychosocial Effects of Insulin Pump Therapy on the Body Image and Self-esteem of Female, Adolescent, Insulin Dependent Diabetics. Chicago, IL: The Chicago School of Professional Psychology; 2013.
63. Rankin D, Harden J, Noyes K, Waugh N, Barnard K, Lawton J. Parents’ experiences of managing their child's diabetes using an insulin pump: a qualitative study. Diabet Med. 2015;32:627-634.
64. Hayes M, Frearson S, Keller C, Cartmale A, Lewis-Hayes S. A hermeneutic phenomenological study of why adults with type 1 diabetes choose to discontinue CSII. Euro Diabetes Nurs. 2011;8:12-16.
65. Forsner M, Berggren J, Masaba J, Ekbladh A, Olinder AL. Parents’ experiences of caring for a child younger than two years of age treated with continuous subcutaneous insulin infusion. Euro Diabetes Nurs. 2014;11:7-12.
66. Shulman R, Miller FA, Daneman D, Guttmann A. Valuing technology: a qualitative interview study with physicians about insulin pump therapy for children with type 1 diabetes. Health Policy. 2016;120:64-71.
67. Olinder AL, Kerstin Ternulf N, Bibbi S. Clarifying responsibility for self-management of diabetes in adolescents using insulin pumps-a qualitative study. J Adv Nurs. 2011;67:1547-1557.
68. Wilson V. Barriers to effective communication between patients using insulin pump therapy technology to enable intensive diabetes self-management and the health professionals providing their diabetes care. J Assist Technol. 2008;2:26-33.
69. Saarinen T, Fernström L, Brorsson A-L, Olinder AL. Insulin pump therapy is perceived as liberating, but to many it can imply a sense of the diabetes made visible. Euro Diabetes Nurs. 2014;11:38-42.
70. Hood DG, Duke G. The nature and meaning of insulin pump use in emerging adults with type 1 diabetes. Diabetes Spectr. 2015;28:75-81.
71. Ferrari M, McIlwain DJ, Ambler G. A qualitative comparison of needles and insulin pump use in children with type 1 diabetes. J Health Psychol. 2016;21. http://journals.sagepub.com/doi/citedby/10.1177/1359105316653999.
72. Everett J, Bowes A, Kerr D. Barriers to improving glycaemic control in CSII. J Diabetes Nurs. 2010;14:176-181.
73. Alsaleh FM, Smith FJ, Thompson R, Taylor KMG. A structured educational insulin pump therapy programme: the views of children/young people and their parents. Euro Diabetes Nurs. 2013;10:25-30.
74. Barnard KD, Wysocki T, Thabit H, et al. Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting. Diabet Med. 2015;32:601-608.
75. Barnard KD, Wysocki T, Allen JM, et al. Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents. BMJ Open Diabetes Res Care. 2014;2:e000025.
76. O'Kane A, Rogers Y, Blandford A. Concealing or revealing mobile medical devices? Designing for onstage and offstage presentation. Proceedings of the 2015 Conference on Human Factors in Computing Systems (CHI-2015); April 18–23, 2015, 2015; Seoul, Republic of Korea.
77. Olinder AL, Nyhlin KT, Smide B. Reasons for missed meal-time insulin boluses from the perspective of adolescents using insulin pumps: ‘lost focus’. Pediatr Diabetes. 2011;12(4pt2):402-409.
78. Todres L, Keen S, Kerr D. Continuous subcutaneous insulin infusion in Type 1 diabetes: patient experiences of ‘living with a machine’. Diabet Med. 2010;27:1201-1204.
79. Perry L, James S, Gallagher R, Dunbabin J, Steinbeck K, Lowe J. Supporting patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: difficulties, disconnections, and disarray. J Eval Clin Pract. 2017;23:719-724.
80. Diabetes UK. State of the Nation England: Challenges for 2015 and Beyond. London: Diabetes UK; 2015.
81. Casey D, Murphy K, Lawton J, White FF, Dineen S. A longitudinal qualitative study examining the factors impacting on the ability of persons with T1DM to assimilate the Dose Adjustment for Normal Eating (DAFNE) principles into daily living and how these factors change over time. BMC Public Health. 2011;11:672.
82. Funnell MM, Brown TL, Childs BP, et al. National standards for diabetes self-management education. Diabetes Care. 2008;31(Suppl 1):S97-S104.
83. Byrne JL, Davies MJ, Willaing I, et al. Deficiencies in postgraduate training for healthcare professionals who provide diabetes education and support: results from the Diabetes Attitudes, Wishes and Needs (DAWN2) study. Diabet Med. 2017;4:1074-1083.
84. Bandura A. Exercise of human agency through collective efficacy. Curr Dir Psychol Sci. 2000;9:75-78.
85. Bandura A. Health promotion from the perspective of social cognitive theory. Psychol Health. 1998;13:623-649.
86. Heller S, White D, Lee E, et al. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial. Health Technol Assess. 2017;21:1-278.
87. Kyngas H. Compliance of adolescents with diabetes. J Pediatr Nurs. 2000;15:260-267.
88. Karlsson A, Arman M, Wikblad K. Teenagers with type 1 diabetes – a phenomenological study of the transition towards autonomy in self-management. Int J Nurs Stud. 2008;45:562-570.
89. Kennedy A, Vassilev I, James E, Rogers A. Implementing a social network intervention designed to enhance and diversify support for people with long-term conditions. A qualitative study. Implement Sci. 2016;11:27.
90. Hempler NF, Joensen LE, Willaing I. Relationship between social network, social support and health behaviour in people with type 1 and type 2 diabetes: cross-sectional studies. BMC Public Health. 2016;16:198.
91. Vassilev I, Rogers A, Sanders C, et al. Social networks, social capital and chronic illness self-management: a realist review. Chronic Illn. 2011;7:60-86.
92. Blickem C, Kennedy A, Vassilev I, Morris R, Brooks H, Jariwala P. Linking people with long-term health conditions to healthy community activities: development of patient-Led assessment for network support (PLANS). Health Expect. 2013;16:e48-e59.
93. Cohen S, Wills TA. Stress, social support, and the buffering hypothesis. Psychol Bull. 1985;98:310-357.
94. Miller TA, DiMatteo MR. Importance of family/social support and impact on adherence to diabetic therapy. Diabetes Metab Syndr Obes. 2013;6:421-426.
95. Ritholz MD, Smaldone A, Lee J, Castillo A, Wolpert H, Weinger K. Perceptions of psychosocial factors and the insulin pump. Diabetes Care. 2007;30:549-554.
96. Vesco AT, Anderson BJ, Laffel LMB, Dolan LM, Ingerski LM, Hood KK. Responsibility sharing between adolescents with type 1 diabetes and their caregivers: importance of adolescent perceptions on diabetes management and control. J Pediatr Psychol. 2010;35:1168-1177.
97. Ingerski LM, Anderson BJ, Dolan LM, Hood KK. Blood glucose monitoring and glycemic control in adolescence: contribution of diabetes-specific responsibility and family conflict. J Adolesc Health. 2010;47:191-197.
98. Barnard KD, Lloyd CE, Dyson PA, et al. Kaleidoscope model of diabetes care: time for a rethink? Diabet Med. 2014;31:522-530.
99. Helgeson VS, Reynolds KA, Siminerio L, Escobar O, Becker D. Parent and adolescent distribution of responsibility for diabetes self-care: links to health outcomes. J Pediatr Psychol. 2008;33:497-508.
100. Harrison S, Stadler M, Ismail K, Amiel S, Herrmann-Werner A. Are patients with diabetes mellitus satisfied with technologies used to assist with diabetes management and coping?: a structured review. Diabetes Technol Ther. 2014;16:771-783.
101. Dixon-Woods M, Cavers D, Agarwal S, et al. Conducting a critical interpretive synthesis of the literature on access to healthcare by vulnerable groups. BMC Med Res Methodol. 2006;6:1-13.
102. NHS Digital. The National Diabetes Audit Insulin Pump Report 2015-16. Leeds: NHS Digital; 2017. Page 3.